Posters at ASH 2024

GTC is excited to be exhibiting at the American Society of Hematology (ASH) conference in San Diego on December 6-9, 2024. You can find us at booth #2548 where we will be showcasing our portfolio of tests for hematologic malignancies that analyze both DNA and RNA. We will also be doing live demonstrations of our new Interprestation software that empowers pathologists to run NGS and perform the analysis in their own labs. 

GTC has 6 posters being presented at ASH in San Diego.  

Clearance of Circulating Multiple Myeloma Cells to Assess Early Response to Bispecific Antibodies in Relapsed/Refractory Multiple Myeloma 

Result Type: Paper 
Number: 4687 
Presenter: Binod Dhakal 
Program: Oral and Poster Abstracts 
Session: 653. Multiple Myeloma: Clinical and Epidemiological: Poster III 
Time and Location: 
Monday, December 9, 2024: 6:00 PM-8:00 PM 
Halls G-H (San Diego Convention Center) 

Authors: 

Binod Dhakal, MBBS¹, Michael Slade, MD, MS², Ravi Narra, MD^3*, Mostafa E. Mohamed^4*, Othman S. Akhtar, MD^1*, Hima Bansal, PhD^5*, Maria Jose Acevedo-Calado, PhD^5*, Oren Pasvolsky, MD^6*, Mahmoud R. Gaballa, MD⁵, Melody R. Becnel, MD⁷, Donna M. Weber, MD⁵, Krina K. Patel, MD, MSc⁸, Sheeba K. Thomas, MD⁷, J Christine Ye, MD^9*, Frank Kuhr^10*, Bamboo Dong^11*, Shemeeakah Powell^10*, Thai Bui^10*, Meera Mohan, MD¹², Marcelo C. Pasquini, MD, MS¹³, Anita D’Souza, MD, MS^1*, Halyna Knysh^10*, Robert Z. Orlowski, MD, PhD⁵, Maher Albitar, MD^14* and Hans C. Lee, MD¹⁵ 

Clonotype-Naïve Detection of Clonality in Patients Suspected of Having Multiple Myeloma or Monoclonal Gammopathy Using Peripheral Blood Cell-Free RNA (cfRNA) 

Result Type: Paper 
Number: 1946 
Presenter: Maher Albitar 
Program: Oral and Poster Abstracts 
Session: 653. Multiple Myeloma: Clinical and Epidemiological: Poster I 
Time and Location: 
Saturday, December 7, 2024: 5:30 PM-7:30 PM 
Halls G-H (San Diego Convention Center) 

Maher Albitar, MD¹, Hong Zhang, MD^1*, Sally Agersborg, MD, PhD^1*, Ahmad Charifa, MD^1*, Pooja Phull, MD^2*, Noa Biran, MD², David H. Vesole, MD, PhD³, Harsh Parmar, MD², Andrew L Pecora, MD⁴, Andrew Ip, MD, MSc⁵, Andre Goy, MD, MS³ and David S. Siegel, MD, PhD⁴ 

Immune and Myeloid Differentiation Shape Transcriptome to Discriminate Evolutionary Stages of Cellular Transformation 

Result Type: Paper 
Number: 2923 
Presenter: Lacey Williams 
Program: Oral and Poster Abstracts 
Session: 618. Acute Myeloid Leukemias: Biomarkers and Molecular Markers in Diagnosis and Prognosis: Poster II 
Time and Location: 
Sunday, December 8, 2024: 6:00 PM-8:00 PM 
Halls G-H (San Diego Convention Center) 

Lacey Scott Williams, MD¹, Anne S. S. Renteria, MD², Maher Albitar, MD^3* and Gustavo A. Rivero, MD^4* 

Establishing a Distinct Cytokine Signature for Multiple Myeloma Using Bone Marrow RNA and Peripheral Blood Cell-Free RNA (cfRNA) 

Result Type: Paper 
Number: 3316 
Presenter: Maher Albitar 
Program: Oral and Poster Abstracts 
Session: 653. Multiple Myeloma: Clinical and Epidemiological: Poster II 
Time and Location: 
Sunday, December 8, 2024: 6:00 PM-8:00 PM 
Halls G-H (San Diego Convention Center) 

Maher Albitar, MD¹, Hong Zhang, MD^1*, Sally Agersborg, MD, PhD^1*, Ahmad Charifa, MD^1*, Pooja Phull, MD^2*, Noa Biran, MD², David H. Vesole, MD, PhD³, Harsh Parmar, MD², Andrew L Pecora, MD⁴, Andrew Ip, MD, MSc⁵, Andre Goy, MD, MS⁶ and David S. Siegel, MD, PhD⁴ 

Establishing Distinct Cytokine Signatures Differentiating between Acute Myeloid Leukemia, Myelodysplastic Syndrome, and Chip Using Bone Marrow RNA or Cell-Free RNA (cfRNA) 

Result Type: Paper 
Number: 4295 
Presenter: Maher Albitar 
Program: Oral and Poster Abstracts 
Session: 618. Acute Myeloid Leukemias: Biomarkers and Molecular Markers in Diagnosis and Prognosis: Poster III 
Time and Location: 
Monday, December 9, 2024: 6:00 PM-8:00 PM 
Halls G-H (San Diego Convention Center) 

Maher Albitar, MD¹, Sally Agersborg, MD, PhD^1*, Ahmad Charifa, MD^1*, Hong Zhang, MD^1*, Andrew Ip, MD, MSc², Katherine Linder, MD^3*, Andrew L Pecora, MD³, Jamie Koprivnikar, MD^4*, Andre Goy, MD, MS² and James McCloskey, MD⁵ 

Establishing Lymphoma Type-Specific Cytokine Signatures Using Tissue-Based RNA or Peripheral Blood Cell-Free RNA (cfRNA) 

Result Type: Paper 
Number: 4367 
Presenter: Maher Albitar 
Program: Oral and Poster Abstracts 
Session: 621. Lymphomas: Translational – Molecular and Genetic: Poster III 
Time and Location: 
Monday, December 9, 2024: 6:00 PM-8:00 PM 
Halls G-H (San Diego Convention Center) 

Maher Albitar, MD¹, Hong Zhang, MD^1*, Sally Agersborg, MD, PhD^1*, Ahmad Charifa, MD^1*, Andrew L Pecora, MD², Lori A. Leslie, MD³, Tatyana Feldman, MD⁴, Andrew Ip, MD, MSc⁵ and Andre Goy, MD, MS⁵